This document summarizes new advances in laparoscopic resection for liver tumors. It discusses the historical challenges of open liver surgery and improved outcomes with laparoscopic techniques. Specific cases are presented of laparoscopic resection for benign cysts and tumors as well as malignant hepatocellular carcinoma and colorectal cancer metastases. The theoretical advantages and solutions for challenges of the laparoscopic approach are reviewed.
New advances in minimally invasive treatment of liver tumors
1. New Advances in the Treatment of Liver Tumors: Laparoscopic Resections Cancer Care Innovations Dorothy E. Schneider Cancer Center Mills-Peninsula Hospital April 23, 2011 Kimberly Moore Dalal, MD, FACS Surgical Oncology and General Surgery Peninsula Medical Clinic Bruce Allen, MD; Aziz Ahmad, MD; Dirk Baumann, MD; John Beare, MD; Pamela Foster, MD; Stephanie Lin, MD; Andrea Metkus, MD; John Rosenman, MD; Randolph Wong, MD; Albert Wetter, MD
9. Benign Hepatic Lesions Liver cancer Tumor Malignant Potential Spontaneous Hemorrhage Focal nodular hyperplasia No No Hemangioma No Rare Cystadenoma Yes No Adenoma Yes Yes
17. Laparoscopic Port Placement for Right Liver Lesions Cho JY, et al. , Arch Surg 2009; 144(1):25-29. Liver cancer
18. Laparoscopic View of the Liver Liver cancer Machado MA, et al ., Surg Endosc, 2009; 23:2615-2619.
19. Case 2: Hepatic Adenoma, Segment 7 Laparoscopic Resection…9 Months Later Liver cancer
20.
21.
22.
23.
24.
25.
26.
27. 23 pts: Negative margins (100%). No local recurrence. Laparoscopic Hepatectomy MSKCC Results (n=44) Liver cancer D’Angelica, MD, et al ., AHPBA 2006 Benign 21 pts (47%) Malignant 23 pts (53%) 1 tumor 36 pts (81%) > 1 tumor 8 pts (18%)
28. Operative Outcome Laparoscopic Hepatectomy MSKCC Results: Comparison to Open Liver cancer D’Angelica, MD, et al ., AHPBA 2006 LLR (n=44) OLR (n=91) p OR time (minutes) 199 161 0.01 Pringle time (minutes) 31 22 0.04 Pringle 45% 75% <0.01 EBL (ml) 161 521 <0.01 Transfusion 2.2% 26% <0.01
29. Laparoscopic Hepatectomy MSKCC Results: Comparison to Open Post-operative Outcome Liver cancer D’Angelica, MD, et al ., AHPBA 2006 LLR (n=44) OLR (n=91) p Length of stay (days) 5.1 6.7 <0.01 Morbidity 13% 28% 0.08 Regular diet (days) 3 3 0.7 Oral analgaesia (days) 3.1 3.5 0.1 Mortality 0% 0% 0
30.
31.
32.
33.
34. Child-Pugh Class A Patients are Candidates for Resection Liver cancer Class A = 5-6 points Good operative risk Class B = 7-9 points Moderate operative risk Class C = 10-15 points Poor operative risk 1 2 3 Encephalopathy None 1-2 3-4 Ascites None Slight Moderate Albumin (g/dL) >3.5 2.8-3.5 <2.8 Prothrombin time (sec) 1-4 4-6 >6 Bilirubin (mg/dL) 1-2 2-3 >3
Hassan technique- initial supraumbilical port RUQ and LUQ ports to take down omental adhesions Divide gastrohepatic ligament with ligasure Left gastric artery was identified and retracted in an anterior location. Base of celiac plexus was visualized. A 22 g needle was sheathed in a plastic sheath and inserted. Area was aspirated, then injected 15 cc of 50% alcohol on either side of the celiac pelxus. No evidence of hypotension or blood aspiration.
Technique- do we isolate vasculature or go through parenchyma
Divide into groups based on margins width- how may > 1cm and how many < 1 cm
OPERATIVE DETAILS
SHORT TERM OUTCOME
Hepatobiliary cancers are highly lethal cancers. 4 million Americans with Hepatitis C 1.5 million Americans with Hepatitis B
Hepatobiliary cancers are highly lethal cancers. 4 million Americans with Hepatitis C 1.5 million Americans with Hepatitis B